What information must be included in the records maintained by a designated representative?

The information that must be included in the records maintained by a designated representative is crucial for compliance with regulatory standards governing the distribution of drugs. This includes the quantity, dosage form, and date of drug transactions.

Having accurate records of the quantity ensures that the representative can track the volume of drugs being handled. This is vital not only for inventory management but also for regulatory reporting purposes, particularly in maintaining transparency in drug distribution to prevent issues such as diversion or mismanagement. The dosage form provides essential information about the specific type of drug, which is important for understanding the context of the transactions, particularly concerning safety and efficacy. Finally, keeping a record of transaction dates is fundamental for tracking the flow of pharmaceuticals over time, which is necessary for compliance, audits, and ensuring that medications are not expired or subject to recall.

The other options, while they may be pertinent to different aspects of business operations, do not specifically address the mandatory record-keeping requirements for designated representatives in the drug distribution process. This distinction makes the requirement for detailed records of drug transactions particularly relevant for oversight and accountability in the industry.